Aberdeen Group
XENE icon

Aberdeen Group’s Xenon Pharmaceuticals XENE Stock Holding History

Aberdeen Group’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5M Sell
609,929
-140,362
-19% -$6.47M 0.06% 282
2025
Q4 		$33.6M Buy
750,291
+171,146
+30% +$7.19M 0.05% 293
2025
Q3 		$23.3M Buy
579,145
+57,653
+11% +$2.03M 0.04% 380
2025
Q2 		$16.3M Buy
521,492
+117,338
+29% +$3.83M 0.03% 471
2025
Q1 		$13.6M Buy
404,154
+120,255
+42% +$4.57M 0.03% 491
2024
Q4 		$11.1M Buy
283,899
+35,588
+14% +$1.47M 0.02% 491
2024
Q3 		$9.78M Buy
248,311
+35,809
+17% +$1.44M 0.02% 526
2024
Q2 		$8.29M Buy
212,502
+180,466
+563% +$7.21M 0.02% 542
2024
Q1 		$1.38M Hold
32,036
– – ﹤0.01% 805
2023
Q4 		$1.48M Buy
+32,036
New +$1.13M ﹤0.01% 800

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return